The Effects of Shock Vancomycin Concentrations on the Formation of Heteroresistance in Staphylococcus aureus
- 31 December 2020
- journal article
- Published by Publishing House OKI in Antibiotics and Chemotherapy
- Vol. 65 (9-10), 3-7
- https://doi.org/10.37489/0235-2990-2020-65-9-10-3-7
Abstract
Glycopeptides are the basis of the treatment of infections caused by MRSA (Methicillin-Resistant Staphylococcus aureus). Previously, it was demonstrated that antibiotic tolerant phenotypes are formed during selection of resistance under the influence of high concentrations of antibiotics. The present study uses a similar in vitro selection model with vancomycin. Clinical isolates of MRSA belonging to genetic lines ST8 and ST239, as well as the MSSA (ATCC29213) strain, were included in the experiment. Test isolates were incubated for five hours in a medium with a high concentration of vancomycin (50 μg/ml). Test cultures were grown on the medium without antibiotic for 18 hours after each exposure. A total of ten exposure cycles were performed. Vancomycin was characterized by bacteriostatic action; the proportion of surviving cells after exposure was 70–100%. After selection, there was a slight increase in the MIC to vancomycin (MIC 2 μg/ml), teicoplanin (MIC 1.5–3 μg/ml) and daptomycin (MIC 0.25–2 μg/ml). According to the results of PAP analysis, all strains showed an increase in the area under curve depending on the concentration of vancomycin after selection, while a heteroresistant phenotype (with PAP/AUC 0.9) was detected in three isolates. All isolates showed walK mutations (T188S, D235N, E261V, V380I, and G223D). Exposure to short-term shock concentrations of vancomycin promotes the formation of heteroresistance in both MRSA and MSSA. Formation of VISA phenotypes is possible during therapy with vancomycin.Keywords
This publication has 20 references indexed in Scilit:
- Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysisScientific Reports, 2020
- Mechanisms and clinical relevance of bacterial heteroresistanceNature Reviews Microbiology, 2019
- Heteroresistance: A cause of unexplained antibiotic treatment failure?PLoS Pathogens, 2019
- Antibiotic tolerance facilitates the evolution of resistanceScience, 2017
- Distinguishing between resistance, tolerance and persistence to antibiotic treatmentNature Reviews Microbiology, 2016
- Frequency of antibiotic application drives rapid evolutionary adaptation of Escherichia coli persistenceNature Microbiology, 2016
- Vancomycin-intermediate resistance in Staphylococcus aureusJournal of Global Antimicrobial Resistance, 2014
- Optimization of lag time underlies antibiotic tolerance in evolved bacterial populationsNature, 2014
- Unipro UGENE: a unified bioinformatics toolkitBioinformatics, 2012
- A Microdilution Plating Method for Population Analysis of Antibiotic-Resistant StaphylococciMicrobial Drug Resistance, 2001